Dwarfism

10 registered clinical trials studyying Dwarfism.

Status	Trial	Sponsor	Phase
Unknown	A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due NCT03535415	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 3
Unknown	Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS NCT03635580	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 3
Active Not Recruiting	A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic NCT03255694	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 2
Unknown	A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature NCT03221088	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 2
Completed	Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq NCT00234533	Ipsen	Phase 3
Completed	A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function NCT01157793	Merck KGaA, Darmstadt, Germany	Phase 4
Completed	Study of Skeletal Disorders and Short Stature NCT00001754	National Human Genome Research Institute (NHGRI)	—
Completed	Issues Surrounding Prenatal Genetic Testing for Achondroplasia NCT00001536	National Human Genome Research Institute (NHGRI)	—
Completed	The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome NCT00001343	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 2
Completed	Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature NCT00001190	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 2